Tiziana Life Sciences to Ring the Closing Bell at Nasdaq
Tiziana Life Sciences to Ring the Closing Bell at Nasdaq GlobeNewswire December 17, 2025 BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces that Executive Chairman […]